Weiyan Tu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Weiyan Tu has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Jing Ning
Hainan Branch, Shanghai Children’s Medical Center, School of Medicine, Shanghai Jiao Tong University
1 shared publication Meijing Wu
Hainan Branch, Shanghai Children’s Medical Center, School of Medicine, Shanghai Jiao Tong University
1 shared publicationMenglu Qin
Department of Gynecology, Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai, China
1 shared publicationNa Luo
Hainan Branch, Shanghai Children’s Medical Center, School of Medicine, Shanghai Jiao Tong University
1 shared publicationRongdi Xu
Department of Obstetrics, International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University
1 shared publicationWeimin Wu
Department of Gynecology, Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai, China
1 shared publication
Latest Publications
- Open Access
- 5 May 2026
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 13, 1795750
Chinese visceral adiposity index outperforms insulin resistance indices in predicting cardiovascular disease risk: a 12-year prospective cohort study
Aims: This study investigated and compared the abilities of seven insulin resistance (IR) indices, including the triglyceride-glucose index (TyG), TyG-waist circumference (TyG-WC), TyG-waist-to-hip ratio (TyG-WHtR), lipid accumulation product (LAP), visceral adiposity index (VAI), Chinese visceral adiposity index (CVAI), and metabolic score for insulin resistance (METS-IR) to predict cardiovascular disease (CVD) among participants without a history of CVD. Methods: The population was recruited from the prospective Asymptomatic Polyvascular Abnormalities Community (APAC) Study in Hebei. This prospective study included 5,194 individuals without history of CVD who were stratified into CVD group and non-CVD group. The seven IR indices (TyG, TyG-WC, TyG-WHtR, LAP, VAI, CVAI, and METS-IR) were calculated. The primary endpoint was CVD. Results: Over a 12-year follow-up period, 373(7.2%) CVD were documented. The seven IR indices were strongly positively associated with CVD risk. Compare to other IR indices, CVAI was the strongest predictor for CVD (HR:1.84 95% CI: 1.45–2.35; p < 0.001) and showed the highest diagnostic value for CVD (AUC: 0.654 95% CI: 0.640–0.666; p < 0.001). Adding CVAI to the based model exhibited the maximum increased on incremental risk stratification for CVD (NRI: 0.355; IDI: 0.010; all p < 0.001). Moreover, there was a non-linear association between CVAI and CVD, with a threshold point of 96.21. The association between CVAI and CVD risk was more prominent among individuals aged<65 years, female, and non-hypertension (all P interaction<0.001). Conclusion: Compared to the other six tested IR indices, CVAI might be the most valuable index to predict and stratify CVD risk, with enhanced prediction in women under 65 years of age. This suggests that strategies aimed at improving risk stratification should incorporate CVAI into risk algorithms.
- 5 May 2026
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 13, 1795750
Open AccessChinese visceral adiposity index outperforms insulin resistance indices in predicting cardiovascular disease risk: a 12-year prospective cohort study
Aims: This study investigated and compared the abilities of seven insulin resistance (IR) indices, including the triglyceride-glucose index (TyG), TyG-waist circumference (TyG-WC), TyG-waist-to-hip ratio (TyG-WHtR), lipid accumulation product (LAP), visceral adiposity index (VAI), Chinese visceral adiposity index (CVAI), and metabolic score for insulin resistance (METS-IR) to predict cardiovascular disease (CVD) among participants without a history of CVD. Methods: The population was recruited from the prospective Asymptomatic Polyvascular Abnormalities Community (APAC) Study in Hebei. This prospective study included 5,194 individuals without history of CVD who were stratified into CVD group and non-CVD group. The seven IR indices (TyG, TyG-WC, TyG-WHtR, LAP, VAI, CVAI, and METS-IR) were calculated. The primary endpoint was CVD. Results: Over a 12-year follow-up period, 373(7.2%) CVD were documented. The seven IR indices were strongly positively associated with CVD risk. Compare to other IR indices, CVAI was the strongest predictor for CVD (HR:1.84 95% CI: 1.45–2.35; p < 0.001) and showed the highest diagnostic value for CVD (AUC: 0.654 95% CI: 0.640–0.666; p < 0.001). Adding CVAI to the based model exhibited the maximum increased on incremental risk stratification for CVD (NRI: 0.355; IDI: 0.010; all p < 0.001). Moreover, there was a non-linear association between CVAI and CVD, with a threshold point of 96.21. The association between CVAI and CVD risk was more prominent among individuals aged<65 years, female, and non-hypertension (all P interaction<0.001). Conclusion: Compared to the other six tested IR indices, CVAI might be the most valuable index to predict and stratify CVD risk, with enhanced prediction in women under 65 years of age. This suggests that strategies aimed at improving risk stratification should incorporate CVAI into risk algorithms.